TXNIP and metabolic dysfunction-associated steatotic liver disease: How to cite this article: Ding, C. et al. New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats.